Herpes simplex virus type 1 (HSV-1) plasmid vectors have a number of attractive features for gene transfer into neurons. In particular, the large size of the HSV-1 genome suggests that HSV-1 vectors might be designed to co-express multiple genes. Here, we report a general strategy for constructing large HSV-1 plasmid vectors that co-express multiple genes. Each transcription unit is linked to an antibiotic resistance gene, and genetic selections are used to assemble large vectors. Using this strategy, we constructed large (26 or 31 kb) HSV-1 vectors that contain two transcription units and two or three genes. These vectors were efficiently packaged into HSV-1 particles using a helper virus-free packaging system. The resulting vector stocks supported the expression of two or three genes in both cultured cells and the rat brain. Potential applications of HSV-1 vectors that co-express multiple genes are discussed.
INTRODUCTION
Gene transfer into neural cells may support both gene therapy of neurological disorders and analyses of neuronal physiology. Many of these applications require specific properties of a virus vector system including high titers, longterm expression, minimal side effects, and, in particular, co-expression of multiple genes. Herpes simplex virus type 1 (HSV-1) plasmid vectors (6) have a number of attractive features, and a growing number of investigators have used this vector system to modify neuronal physiology (5) . Gene transfer with helper virus vector systems results in significant cytopathic effects and an immune response (8) ; therefore, we developed a helper virus-free HSV-1 system that produces substantially less cytopathic effects and cell infiltration (4) . One of the principal problems with all HSV-1 vectors has been the lack of longterm expression; thus, we recently reported a tyrosine hydroxylase (TH)neurofilament heavy subunit (NFH) chimeric promoter that enhances long-term expression in forebrain neurons (21) .
Although a number of virus vector systems can accommodate only relatively small inserts, one of the potential advantages of HSV-1 plasmid vectors is that the large size of the HSV-1 genome [approximately 152 kb (15) ] suggests that large vectors co-expressing multiple genes might be developed. HSV-1 plasmid vectors are packaged as headto-tail concatamers to achieve a genome-sized DNA molecule. Thus, large vectors that can form concatamers of approximately 150 kb might be correctly packaged. S. Wang et al. (19) have shown that a 30-kb vector can be packaged using a helper virus system, and X. Wang et al. (20) have shown that a 50-kb vector can be packaged using a helper virus-free system. There are a few reports of specific HSV-1 vectors that co-express two genes; New and Rabkin (14) have reported a HSV-1 vector that expresses two histological markers (LacZ and alkaline phosphatase), and Ho et al. (7) and Fotaki et al. (3) have reported vectors that express two genes-a tetracycline-regulated transcription factor and a reporter gene.
In this study, we describe a general strategy for constructing large HSV-1 vectors that co-express multiple genes. Each transcription unit is constructed separately and is linked to an antibiotic resistance gene. Genetic selections for antibiotic resistance are first used to link individual transcription units together and then to insert an array of transcription units into an HSV-1 vector. The resulting vectors support expression of multiple genes in both cultured cells and the rat brain.
MATERIALS AND METHODS

Plasmid Constructions
We constructed (Figure 1 ) a plasmid for linking a single transcription unit to a specific antibiotic resistance gene and flanked by sites for a specific restriction endonuclease with an 8-bp recognition sequence. Two oligonucleotides, 5′-AATTG GGCCGGCCGATATCCT-CGAGCAGT CGGAATTCGGAAGG-AGATCT GTTAACGGCCGGCCA-3′ and 5′-GGCCTGGCCGGCCGTTAA-CAGAT CTCCTTCCGAATTCCGAC-TGCTCGA GGATATCGGCCGGC-CC-3′, were inserted into the EagI and EcoRI fragment of pBR322 to yield pBRindi-linkerI. An EcoRI and BamHI fragment from pINS-NFHlac [mouse αglobin second intron and simian virus 40 (SV40) early region polyadenylation site (poly A); (21)] was inserted into the EcoRI and BglII fragment of pBRindi-linkerI to yield pBRindi-linker-intronA + . A 63-bp linker (Promega, Madison, WI, USA) (from pSP73; XhoI-EcoRI) was inserted into the XhoI and EcoRI fragment of pBRindi-linker-intronA + to yield pBRindi-73linker-in-tronA + . A BamHI and NdeI fragment from pACYC177 (New England Biolabs, Beverly, MA, USA) [kanamycinresistance gene (Kn r )] was treated with Klenow enzyme and was then inserted into pBRindi-73linker-intronA + , which had been digested with EcoRV and treated with calf intestinal phosphatase (CIP) to yield pBRindi-73linker-in-tronA + -Kn r -FseI.
To allow a transcription unit and the Kn r gene to be excised using a different restriction enzyme, we added PmeI sites to the ends of the polylinker in pBRindi-7 linker-intronA + -Kn r -FseI.
Two oligonucleotides, 5′-AATTGGTTTAA-ACGG CCGGCCGTTTAAACA-3′ and 5′-GGCCTGTTTAAACGGCCGGCC-GTTTAAACC-3′ (PmeI, FseI, and PmeI sites), were inserted into the EagI and EcoRI fragment of pBR322 to yield pBR-PmeI-linker. The FseI fragment from pBRindi-73linker-intronA + -Kn r -FseI was inserted into pBR-PmeI-linker that had been digested with FseI and treated with CIP to yield pBRindi-73linker-intronA + -Kn r -PmeI.
To allow a transcription unit to be linked to a second antibiotic resistance gene, we constructed a plasmid that contains the chloramphenicol-resistance gene (Cm r ). A PshAI and BsaAI fragment from pACYC184 (New England Biolabs) was inserted into pBRindi-73linker-intronA + that had been digested with EcoRV and treated with CIP to yield pBRindi-73linker-intronA + -Cm r -FseI.
Two oligonucleotides, 5′-CGGAG-AAGGCCGGCC GTTTAAACATT-TAAATCACCGGTGC-3′ and 5′-TCG-AGCACCGGTGATTTAAATGTTTA-CGGCCGGCCTTCTCCGGGCC-3′, were inserted into the ApaI and XhoI fragment of pBRlinker (20) to yield pBR-8cutter-linkerI (i.e., a polylinker with PacI, AseI, and NotI sites on each end; 8-cutter plasmid) ( Figure 1 ).
We constructed a transcription unit that contains the TH-NFH promoter (21), the TH gene, an internal ribosome entry site (IRES), and the aromatic amino acid decarboxylase gene (AADC) (13) . A SalI and HindIII fragment from pINS-TH-NFHlac [chicken β-globin insulator (INS) and TH-NFH promoter (2,21)], a FseI and HindIII fragment from p747 [part of TH gene (13)], and a FseI and EcoRI fragment from p747 (remainder of TH gene, IRES, and AADC gene) were inserted into the SalI and EcoRI fragment of pBRindi-73linker-intronA + -Kn r -PmeI to yield pBR-TH-NFHth/ires/aadc-Kn r -PmeI.
We constructed a transcription unit that contains the TH-NFH promoter and a constitutively active protein kinase C (pkc∆) [from rat PKC βII isoform; (16) ]. A SalI and HindIII fragment from pINS-TH-NFHlac and a HindIII and BglII fragment from pHSVpkc∆ were inserted into the SalI and BamHI fragment of pBRindi-73linker-intronA + -Cm r -FseI to yield pBR-TH-NFHpkc∆-Cm r -FseI. We constructed a transcription unit that contains the TH-NFH promoter and the LacZ gene. A SalI and HindIII fragment from pINS-TH-NFHlac and a HindIII and BamHI fragment from pINS-NFHlac [LacZ, mouse α-globin second intron, and SV40 early region poly A site (21)] were inserted into the XhoI and BamHI fragment of pBR-8cutter-linkerI to yield pBR-8cutter-linkerI/TH-NFHlac.
Transcription units were excised by digestion with the appropriate enzyme (PmeI or FseI) and were inserted into pBR-8cutter-linkerI/TH-NFHlac, which had been digested with either PmeI or FseI and treated with CIP. Colonies were selected on DH5α, HB101, SURE, or JM109 cells in the presence of either Kn or Cm.
The arrays of transcription units were excised by digestion with PacI and were inserted into pHSVpUC-link-erI (HSV-1 vector backbone plasmid) ( Figure 1 ) (20) that had been digested with PacI and treated with CIP.
Vector Packaging and Titering
Vectors were packaged into HSV-1 particles using the helper virus-free packaging system (4) as modified to improve the titers (18). Vector stocks were (11) . Vector stocks were titered by counting the number of expressing cells obtained one day after the infection of baby hamster kidney fibroblast cells (BHK21). E. coli β-galactosidase (β-gal) was detected using X-gal (17) . TH, AADC, and Pkc∆ were detected by immunocytochemistry using the procedure described by Song et al. (16) . The TH was fused to the HA epitope tag and was detected using a rabbit anti-HA antibody in a dilution of 1:1000 (CRP, Richmond, CA, USA), human AADC was detected using a rabbit anti-human AADC antibody in a dilution of 1:500 (9), and Pkc∆ was fused to the flag epitope tag and was detected using a mouse monoclonal antiflag antibody in a dilution of 1:1000 (M5; Sigma, St. Louis, MO, USA).
Stereotactic Injections, Histology, and Cell Counts
Male Sprague Dawley rats (striatum) or male Long Evans rats (postrhinal cortex) (100-125 g) were used for these experiments. The procedures for the stereotactic injections, including the injection coordinates, have been described by Zhang et al. (21) . These studies were approved by the Children's Hospital IACUC.
Procedures for perfusions, X-gal staining, and immunohistochemistry have been previously described (21). β-gal was also detected using a rabbit anti-E. coli β-gal antibody in a 1:500 dilution (ICN Biomedicals, Costa Mesa, CA, USA).
For each recombinant protein, every fourth section (25-µm sections) was analyzed, and approximately 10 of these sections contained the positive cells. Positive cells were identified under low power (10×), and morphology was verified under high power (40×). Each section was counted at least two times on different days; the results differed by less than 10%.
RESULTS AND DISCUSSION
General Strategy for Constructing Vectors that Contain Multiple Transcription Units
The construction strategy (Figure 1) is to link each transcription unit to an antibiotic resistance gene, use genetic selections to isolate a plasmid that contains multiple transcription units, and then insert the array of transcription units into an HSV-1 vector using a genetic selection. Initial attempts to construct these vectors without using genetic selections were not successful, possibly because of the large size of the vectors.
Individual gene plasmids support the routine construction of a transcription unit and subsequent insertion of the transcription unit into an HSV-1 vector. These plasmids (Figure 1 ) contain a polylinker for inserting a promoter and gene proximal to an intron and poly A site. These plasmids also contain an EcoRV site for the insertion of an antibi-otic resistance gene; as EcoRV yields blunt ends, virtually any antibiotic resistance gene or other selectable marker may be inserted. We derived plasmids that contain either the Kn r or Cm r genes because the use of multiple antibiotic resistance genes may be useful for constructing arrays of multiple transcription units. For the insertion of a boundary element, such as a matrix attachment region (MAR), there is an HpaI site (blunt ends) at one end of the polylinker to accept a transcription unit. In these plasmids, the transcription unit and antibiotic resistance gene are flanked by sites for a specific endonuclease with an 8-bp recognition sequence, which is used to excise the transcription unit and antibi-
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Figure 1. Diagram of the strategy for constructing HSV-1 vectors that contain multiple genes. An individual gene plasmid contains an
EcoRV site for inserting an antibiotic resistance gene, a polylinker (XhoI, PvuII, HindIII, SphI, PstI, AccI, SalI, XbaI, BamHI, SmaI, KpnI, SacI, and EcoRI) for inserting a promoter and gene, an intron and poly A site, a HpaI site for inserting boundary elements such as a MAR, and the entire array is flanked on each end by an 8-bp site for an endonuclease (FseI in the example shown). An 8-cutter plasmid contains four sites (FseI, PmeI, SwaI, and SgrAI) to receive individual transcription units (inserted using a selection for the specific antibiotic resistance gene), a polylinker (XhoI, PvuII, HindIII, SphI, PstI, AccI, SalI, XbaI, BamHI, HindIII, and BglII) for the direct insertion of a transcription unit, and this array is flanked on each end by PacI, AscI, and NotI sites to excise the array of transcription units. An HSV-1 vector backbone plasmid contains an HSV-1 a sequence (packaging site), PacI, AscI, and NotI sites to insert an array of transcription units using a selection for a specific antibiotic resistance gene, and an HSV-1 origin of DNA replication (HSV-1 ori s ). The HSV-1 ori s fragment contains an HSV-1 IE 4/5 promoter that is separated from the PacI, AscI, and NotI sites by three poly A sites (TriA) (12) . The pBR sequences (horizontal lines) in each plasmid contain the amp r gene and the ColE1 origin of DNA replication. F, FseI; R, EcoRV; H, HpaI; P, PacI; A, AscI; N, NotI; Pm, PmeI; Sw, SwaI; and Sg, SgrAI. otic resistance gene.
To construct arrays of multiple transcription units or to insert a gene or promoter that contains a specific site, it may be useful to flank specific transcription units (and antibiotic resistance genes) with sites for different endonucleases. A second set of flanking sites can be added, by isolating a plasmid that contains the first site flanked on each side by the second site and then by inserting the polylinker and antibiotic resistance gene at the first site. Using this procedure, we added PmeI sites to a polylinker and antibiotic resistance gene that is flanked by FseI sites.
An 8-cutter plasmid for accepting the transcription units (Figure 1 ) con-tains a polylinker with a number of 8bp sites and additional sites (6-bp recognition sequences) for directly inserting a transcription unit. To enable the excision of the resulting array of transcription units, the polylinker is flanked on each end by sites for three enzymes with 8-bp recognition sequences (PacI, AscI, and NotI). The order of these sites allows the array of transcription units to be excised using any enzyme alone or any combination of two enzymes.
An HSV-1 vector backbone plasmid was constructed to accept an array of transcription units (Figure 1 ). This vector contains the two sequences required to package a vector into HSV-1 particles NFHlac (D;l-) . This TH contains the HA tag (13) and was detected using an anti-HA antibody. AADC was detected using an anti-human AADC antibody. β-gal was detected with X-gal (16) . (i.e., HSV-1 origin of DNA replication and HSV-1 packaging site) and the three 8-bp sites that flank the array of transcription units in the 8-cutter plasmid.
The resulting HSV-1 vectors contain the antibiotic resistance gene(s) used in the construction, but, because antibiotic resistance genes are prokaryotic, they are unlikely to be expressed in mammalian cells.
HSV-1 Vectors that Co-Express Two or Three Genes
All of the transcription units use the TH-NFH promoter that supports longterm expression, and the TH-NFH promoter is preceded by an insulator (INS) that further enhances long-term expression (21). We used a construct (13) that contains a TH gene, an IRES, and an AADC gene to co-express TH and AADC. The second transcription unit in these vectors expresses the LacZ gene. Alternatively, we derived vectors in which one transcription unit expresses Pkc∆ (16) and the second transcription unit contains the LacZ gene. We obtained vectors in which the transcription units were in either a sequential or a divergent orientation, and vectors in which the transcription units had different orientations relative to the vector backbone ( Table 1 ). The vectors that contain the TH, AADC, and LacZ genes are 31.3 kb, and the vectors that contain the pkc∆ and LacZ genes are 26.2 kb. Attempts to obtain vectors with three transcription units were unsuccessful possibly because of the large amount of repeated sequence in each of the three copies of the 7.8-kb INS-TH-NFH promoter fragment.
These vectors were packaged into HSV-1 particles using a helper virusfree packaging system (4, 18) . For titer-ing, immunocytochemical or enzymatic assays (see Materials and Methods) were performed one day after infection of BHK cells with these vector stocks. These stocks showed high titers of each of the two or three genes in a specific vector ( Table 1 ). Note that the titers of each of the two or three genes in a specific vector were similar, which was consistent with the co-expression of the D;l-) . Pkc∆ contains the flag tag (16) and was detected using an anti-flag antibody that was visualized using a rhodamine-conjugated secondary antibody. β-gal was detected using an anti-β-gal antibody that was visualized using a fluoresceinconjugated secondary antibody. In the striatum, HA-IR, AADC-IR, or X-gal were assayed in adjacent sections (mean ± SEM; n = three rats). In the postrhinal cortex, β-gal-IR and Pkc∆ were assayed in the same sections; one section from each of the three rats was examined. genes. Comparisons of the titers of each of the genes in these vectors show that the orientation of the transcription units relative to each other or to the vector backbone did not appear to affect the titers. The small differences in the titers among the different genes might reflect differences in either the sensitivities of the assays or in expression of the different genes. In particu-lar, the slightly higher titers of the LacZ gene observed in some vector stocks may be because the X-gal assay is more sensitive than the immunocytochemical assays and these slightly higher titers were not specific to one orientation of the LacZ gene, relative to either the other transcription unit or the vector backbone. These titers (Table 1) are similar to those obtained using smaller vectors that express only one gene (4, 18, 20, 21) . Vector stocks were microinjected into either the striatum or the postrhinal cortex, and the rats were sacrificed four days later. In the striatum (Figure 2) , we observed similar numbers of TH [HA-immunoreactivity (IR)], AADC-IR, or X-gal-positive cells in adjacent sections ( Table 2 ). The slightly lower number of AADC-IR cells may be because this assay is not as sensitive as the other assays. In the postrhinal cortex (Figure 3) , we observed 96% co-localization of β-gal-IR and Pkc∆ (flag-IR) to the same cells (Table 2) . Thus, it appears that the repeated sequences in these vectors are relatively stable, which is consistent with the presence of both inverted and direct repeats in the genome of wild-type HSV-1. Many of the positive cells in the striatum or postrhinal cortex displayed neuronal morphology. Consistent with this neuronal morphology, using pTH-NFHlac, we have shown (21) that approximately 90% of the β-gal-IR positive cells contain a neuronal marker. In the present study, the rats were sacrificed four days after gene transfer; however, we have shown that pTH-NFHlac supports expression for six months in the striatum (21) and that the vector that co-expresses Pkc∆ and LacZ supports expression for three weeks in the postrhinal cortex (unpublished data).
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Potential Applications
Co-expression of multiple genes might support gene transfer of the multiple subunits of a protein or a relatively complete biosynthetic pathway, signal transduction pathway, or other pathway. For example, regarding gene therapy for Parkinson's disease, TH and GTP cyclohyrolase have been shown to support the efficient production of L-DOPA (1); AADC converts L-DOPA to dopamine, and a vesicular monoamine transporter sequesters dopamine into synaptic vesicles, both enabling the regulated release of dopamine and relieving end-product (dopamine) inhibition of TH (10). Thus, co-expression of all four genes in striatal neurons might be an effective approach for correcting the symptoms of Parkinson's disease.
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